July 9, 2021 — The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to automate segmentation and measurement of suspicious objects across all medical imaging modalities, delivering critical improvements in workflow and reporting precision.

July 8, 2021 — Intelerad Medical Systems, a global leader in medical image management solutions, announced its acquisition of Heart Imaging Technologies (HeartIT), the leader in clinical workflow automation. Headquartered in the Raleigh-Durham area, HeartIT provides web-based medical image management technology and services to health systems, large hospitals and private clinics, as well as drug and device companies sponsoring multi-center clinical trials.

July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting, which will return to an in-person conference at McCormick Place West in Chicago, October 24-27, 2021. General registration is available at www.astro.org/annualmeeting.

July 8, 2021 — Fujifilm Medical Systems U.S.A., Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Fujifilm’s new image enhancement technology - the Oxygen Saturation Endoscopic Imaging System - which was developed to improve visualization during gastrointestinal, colorectal, and advanced endoscopy and surgical procedures.

July 8, 2021 — Biogen and Eisai Co., Ltd. announced the U.S. Food and Drug Administration (FDA) has approved an updated label for Aduhelm (aducanumab-avwa) injection 100 mg/mL solution.

July 7, 2021 — Annalise.ai has launched its comprehensive chest X-ray AI solution Annalise CXR, which detects 124 clinical findings and is a decision support tool for radiologists and clinicians. The company was originally formed as a joint venture between Australian healthcare technology company Harrison.ai and one of the world’s largest radiology companies, I–MED Radiology Network. 


The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment practices.

July 7, 2021 — Amid the COVID-19 crisis, the global market for single photon emission computed tomography (SPECT) estimated at $1.7 billion in the year 2020, is projected to reach a revised size of $2.7 billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now